Genedrive (GDR): Mr David Nugent campaign
This situation live
GDR Genedrive
10 Sep 2025 · 5.6% · −69% until the next step
Mr David Nugent: 5.6%
1 Oct 2025 · 3.43% · +4% until the next step
Mr David Nugent: 3.43% (from 5.6%)
2 Oct 2025 · 10.1% · +51% until the next step
Mr David Nugent: 10.1% (from 6.15%)
9 Oct 2025 · campaign · +12% until the next step
The Equity Financing announced on 23 September 2025 was the only certain financing option available to it
10 Oct 2025 · 15.1% · +86% until the next step
Mr David Nugent: 15.1% (from 12.24%)
10 Oct 2025 · 12.24% · +86% until the next step
Mr David Nugent: 12.24% (from 10.1%)
29 Oct 2025 · 16.035% · +39% until the next step
Mr David Nugent: 16.035% (from 15.1%)
24 Feb 2026 · 20.72% · −7% until the next step
Mr David Nugent: 20.72% (from 19.02%)
6 May 2026 · campaign · +16% since
Mr David Nugent: 25.01% (from 24.65%)
Mr David Nugent campaign
campaign
ActivistMr David Nugent
Stake25.01%
Their caseThe Shareholder has made several posts about the Company and the recent Equity Financing in which he has called for alternative forms of financing to fund the Company. ↗
As of 6 May 2026 ↗
Since Oct 2023: 144 situations of this kind – went quiet 75%, activist sold out 18%, settled with the board 4%, requisition withdrawn 2%, the activist's resolutions were voted down 1%; median share price +5% six months after they opened
Every step · 9
- 10 Sep 2025 5.6% – Mr David Nugent: 5.6% ↗
- 1 Oct 2025 3.43% – Mr David Nugent: 3.43% (from 5.6%) ↗
- 2 Oct 2025 10.1% – Mr David Nugent: 10.1% (from 6.15%) ↗
- 9 Oct 2025 campaign – The Equity Financing announced on 23 September 2025 was the only certain financing option available to it ↗
- 10 Oct 2025 15.1% – Mr David Nugent: 15.1% (from 12.24%) ↗
- 10 Oct 2025 12.24% – Mr David Nugent: 12.24% (from 10.1%) ↗
- 29 Oct 2025 16.035% – Mr David Nugent: 16.035% (from 15.1%) ↗
- 24 Feb 2026 20.72% – Mr David Nugent: 20.72% (from 19.02%) ↗
- 6 May 2026 campaign – Mr David Nugent: 25.01% (from 24.65%) ↗
What is happening
Genedrive: Mr David Nugent campaign – campaign. ['campaign']
- In short
- Mr David Nugent holds 25.01% of Genedrive.
- Announced
- 10 Sep 2025 · 5.6%
- Latest
- 6 May 2026 · 25.01%
From the company's own announcements. Not investment advice.
Briefing Pro
New to Genedrive? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the GDR briefing →Also at Genedrive 1 open
Project milestonesNHS England MT-RNR1 national tender – PALOH-UK recruitment complete; NICE technology appraisal
Balance-sheet stress / refinancingShareholder loan funding – Loan converted to equity; company debt free · closed
Dilutive fundraiseEquity raise up to £6m – Completed March 2026 · closed
Upgrade / downgrade cycleProfit warning – profit warning · second in 12 months · closed
Upgrade / downgrade cycleProfit upgrade – guidance raised · closed
Genedrive – company page →